Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.

Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA.

Int J Med Microbiol. 2007 Jun;297(3):151-62. Epub 2007 Apr 19.

PMID:
17448724
2.

Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.

Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA.

Int J Med Microbiol. 2008 Jan;298(1-2):105-14. Epub 2007 Oct 23. Review.

PMID:
17936683
3.

Tumor-targeting amino acid auxotrophic Salmonella typhimurium.

Hoffman RM.

Amino Acids. 2009 Sep;37(3):509-21. doi: 10.1007/s00726-009-0261-8. Epub 2009 Mar 17. Review.

PMID:
19291366
4.

[Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].

Xia P, Zhu J, Zhu G.

Wei Sheng Wu Xue Bao. 2013 Jun 4;53(6):538-44. Review. Chinese.

PMID:
24028055
5.

Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.

Jacobi CA, Malfertheiner P.

Dig Dis. 2011;29(6):600-7. doi: 10.1159/000333307. Epub 2011 Dec 12. Review.

PMID:
22179217
6.

[Anaerobic bacteria as a gene delivery system for breast cancer therapy].

Fujimori M.

Nihon Rinsho. 2008 Jun;66(6):1211-8. Review. Japanese.

PMID:
18540373
7.

Insights from 100 Years of Research with Probiotic E. Coli.

Wassenaar TM.

Eur J Microbiol Immunol (Bp). 2016 Sep 29;6(3):147-161. eCollection 2016 Sep 29. Review.

Supplemental Content

Support Center